Latest RVMD reports update at 2024-05-08: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Revolution Medicines RVMD

$ 37.45 -2.24%

Revolution Medicines Financial Statements 2011-2024 | RVMD

Annual Financial Statements Revolution Medicines

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	3.44 B	1.99 B	1.57 B	2.31 B	-	-	-	-	-	-	-	-	-
Shares	113 M	80.6 M	72.8 M	54.9 M	-	-	-	-	-	-	-	-	-
Historical Prices	30.4	24.6	21.5	42.1	-	-	-	-	-	-	-	-	-
Net Income	-436 M	-249 M	-187 M	-108 M	-47.7 M	-41.8 M	-31.1 M	-	-	-	-	-	-
Revenue	11.6 M	35.4 M	29.4 M	43 M	50 M	20.2 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-487 M	-258 M	-188 M	-111 M	-54.1 M	-40.3 M	-	-	-	-	-	-	-
Interest Expense	-	-	-	71 K	106 K	116 K	-	-	-	-	-	-	-
EBITDA	-482 M	-254 M	-185 M	-108 M	-50.8 M	-38.6 M	-29.8 M	-	-	-	-	-	-
Operating Expenses	499 M	294 M	217 M	154 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	75.6 M	40.6 M	30.4 M	21.4 M	12.4 M	9.41 M	4.54 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Revolution Medicines

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	165 M	165 M	109 M	107 M	94.8 M	90.4 M	84.7 M	74.3 M	74.2 M	74.1 M	73.5 M	73.4 M	70.4 M	66.6 M	64.9 M	58.8 M	29.3 M	3.29 M	2.81 M	2.72 M	2.64 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-116 M	-	-108 M	-98.3 M	-68.1 M	-	-73.3 M	-61.2 M	-57.6 M	-	-52.9 M	-44.3 M	-37.2 M	-34.2 M	-27.2 M	-27.2 M	-19.5 M	-14.6 M	-12.8 M	-10.1 M	-10.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	3.82 M	7.01 M	-	3.36 M	9.12 M	7.58 M	-	1.1 M	8.7 M	10.1 M	8.75 M	12.7 M	10 M	11.5 M	12.1 M	12.5 M	12.3 M	13.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-141 M	-	-123 M	-109 M	-75.2 M	-	-76.5 M	-62.1 M	-57.9 M	-	-53.2 M	-44.5 M	-37.4 M	-	-27.6 M	-28 M	-21.1 M	-	-13.6 M	-10.6 M	-10.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	12 K	-	17 K	19 K	21 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-139 M	-	-122 M	-108 M	-74 M	-	-75.5 M	-61.2 M	-57 M	-	-50.9 M	-43.1 M	-36.7 M	-	-25.6 M	-26.7 M	-20.4 M	-	-11.9 M	-9.49 M	-9.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	141 M	-	123 M	113 M	82.2 M	-	79.9 M	71.2 M	65.5 M	-	54.3 M	53.2 M	47.5 M	-	40.2 M	38 M	32.6 M	-	26.1 M	22.8 M	23.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	22.8 M	-	15.5 M	14.6 M	13.2 M	-	10.4 M	10.2 M	9.04 M	-	7.79 M	7.3 M	6.67 M	-	5.34 M	5.09 M	5.17 M	-	3.1 M	2.72 M	2.42 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency